ARGX

Argenx Adds Two New Indications To The FcRn Pool (NASDAQ:ARGX)

RBC Capital raises argenx stock price target on myositis data

These Analysts Boost Their Forecasts On Argenx

Citizens raises argenx stock price target to $1,200 on trial results

Why argenx (ENXTBR:ARGX) Is Up 11.5% After Positive Autoimmune Myositis Phase 3 Data And What's Next

Argenx's Positive Vyvgart Data in Autoimmune Indication Supports Growth and FB102 Broadens Portfolio

Argenx Breaks Out On Another Big Score For Vyvgart

TD Cowen raises argenx stock price target to $1,353 on myositis outlook

Argenx Stock Is Having Its Best Day Ever. The Biotech’s Biggest Drug Could Get Even Bigger.

Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win

$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today

Why Is Argenx Stock Soaring Monday? - argenx (NASDAQ:ARGX)

Argenx shares jump after positive Phase 3 results in autoimmune myositis trial

Hedge Funds Favor argenx (ARGX) Over Forte Biosciences, Inc. (FBRX): Argenx Agrees to Buy Forte Biosciences

argenx (ENXTBR:ARGX) Draws Fresh Valuation Debate, Is The Stock Overvalued Or Undervalued?